YARN IMAGING DEVICE
    1.
    发明公开
    YARN IMAGING DEVICE 审中-公开

    公开(公告)号:EP3405776A1

    公开(公告)日:2018-11-28

    申请号:EP17707086.9

    申请日:2017-01-18

    IPC分类号: G01N21/892

    CPC分类号: G01N21/892

    摘要: The present invention provides a yarn imaging device (100) comprising one or more sensing groups (110). Each sensing group comprises at least one illumination source (114) for illuminating the yarn (10) and at least one digital image sensor (111). The digital image sensor is positioned in such a way that the digital image sensor generates an image of the yarn (10). The characteristics of the yarn are determined based on the yarn image. Further, the present invention enables determination of presence of foreign matter within the yarn.

    Composition comprising ferrocene-derivatives and fuel composition comprising such derivatives
    2.
    发明公开
    Composition comprising ferrocene-derivatives and fuel composition comprising such derivatives 有权
    Zusammensetzung enthaltend Ferrocen-Derivate und Treibstoff diese enthaltend

    公开(公告)号:EP1826214A1

    公开(公告)日:2007-08-29

    申请号:EP07011727.0

    申请日:2002-08-29

    摘要: The present invention provides a composition comprising: i) at least one compound of formula (I):

    wherein R 1 and R 2 are independently selected from a group consisting of hydrogen, unsubstituted or substituted C 1-19 hydrocarbyl or a group of formula (II):

    wherein Q is a bond or an unsubstituted or substituted hydrocarbyl group; wherein R 3 is selected from a group consisting of hydrogen and unsubstituted or substituted C 1-18 hydrocarbyl ; wherein the R 1 -C-R 2 backbone is from 5 to 20 atoms in length; wherein each A and B is independently an unsubstituted or substituted unsaturated cyclic hydrocarbyl group; and wherein n is an integer from 0 to 10; and ii) a diluent or carrier; wherein the compound(s) of formula (I) is present in an amount sufficient to provide, at-30°C, at least 1 wt % of iron, based on the weight of the composition.

    摘要翻译: 本发明提供一种组合物,其包含:i)至少一种式(I)化合物:其中R 1和R 2独立地选自氢,未取代或取代的C 1-19烃基或式( II):其中Q是键或未取代或取代的烃基; 其中R 3选自氢和未取代的或取代的C 1-18烃基; 其中R 1 -C-R 2主链的长度为5至20个原子; 其中每个A和B独立地是未取代或取代的不饱和环烃基; 并且其中n为0至10的整数; 和ii)稀释剂或载体; 其中式(I)化合物的存在量足以提供基于组合物重量的-30℃至少1重量%的铁。

    Compositions comprising dimeric or oligomeric ferrocenes
    3.
    发明公开
    Compositions comprising dimeric or oligomeric ferrocenes 审中-公开
    Z。。。。。。。。。。。。。

    公开(公告)号:EP1792908A1

    公开(公告)日:2007-06-06

    申请号:EP07004443.3

    申请日:2001-08-30

    申请人: Innospec Limited

    IPC分类号: C07F17/02 C10M139/06

    CPC分类号: C10L10/02 C10L1/305 C10L10/06

    摘要: The present invention relates to iron-organo compounds and the use of such compounds in the regeneration of particulate filter traps in combustion systems such as high-compression spontaneous ignition engines. The iron-organo compounds have the formula X-Y where X represents the group of formula

    Y represents the formula

    each A and B is independently an unsubstituted or substituted aromatic carbon ring or an unsubstituted or substituted aromatic heterocyclic ring; the or each Z is independently an unsubstituted or substituted divalent hydrocarbyl group; n is 0 or an integer of from 1 to 10.

    摘要翻译: 本发明涉及铁 - 有机化合物以及这些化合物在诸如高压缩自发点燃发动机的燃烧系统中再生颗粒过滤器捕集器中的用途。 铁 - 有机化合物具有式X-Y,其中X表示式Y基团,其中A和B各自独立地为未取代或取代的芳族碳环或未取代或取代的芳族杂环; 该或每个Z独立地为未取代或取代的二价烃基; n为0或1〜10的整数。

    COMPRESSED TABLET COMPOSITION COMPRISING A NSAID
    8.
    发明授权
    COMPRESSED TABLET COMPOSITION COMPRISING A NSAID 有权
    简明含制备的NSAIDs

    公开(公告)号:EP1235558B1

    公开(公告)日:2006-05-03

    申请号:EP00990644.7

    申请日:2000-11-30

    IPC分类号: A61K9/20 A61K31/19

    摘要: A compressed tablet composition comprising:a granular component comprising a plurality of solidified melt granules of a non-steroidal anti-inflammatory drug (NSAID) having a melting point in the range 30-300 DEG C and incorporating a disintegrant uniformly dispersed therein; characterised in that the granules comprise a continuous phase of said non-steroidal anti-inflammatory drug and further characterised in that the tablet composition comprises silicon dioxide present in an amount of 0.05-5.0 % by weight of the composition. Preferably, the composition also contains an extra-granular component comprising the silicon dioxide and a lubricant. Further preferably the NSAID is ibuprofen which has a melting point in the range 75-77 DEG C. Optionally the melting process can be carried out in an extruder. Tablets containing advantageous processing properties and dissolution characteristics are obtained.